Rebaudioside C 50 mg | 99.85%
TargetMol
Dulcoside B (Rebaudioside C) is a natural sweeteners used for diabetics and others on carbohydrate-controlled diets.
More Information Supplier PageRebaudioside C
Search Results
Antitumor agent-21 10 mg | Purity Not Available
TargetMol
Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
More Information Supplier PageAntitumor agent-21
Antitumor agent-21 25 mg | Purity Not Available
TargetMol
Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
More Information Supplier PageAntitumor agent-21
Antitumor agent-21 50 mg | Purity Not Available
TargetMol
Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
More Information Supplier PageAntitumor agent-21
Antitumor agent-21 5 mg | Purity Not Available
TargetMol
Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
More Information Supplier PageAntitumor agent-21
Liquiritigenin 50 mg | 99.70%
TargetMol
Liquiritigenin, a flavonoid aglycone from licorice, is a highly selective estrogen receptor β (ERβ) agonist.
More Information Supplier PageLiquiritigenin
Dizocilpine Maleate 50 mg | 99.96%
TargetMol
Dizocilpine Maleate (MK 801) is a potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) with Kd of 37.2 nM in rat brain membranes. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role.
More Information Supplier PageDizocilpine Maleate
Dizocilpine Maleate 25 mg | 99.96%
TargetMol
Dizocilpine Maleate (MK 801) is a potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) with Kd of 37.2 nM in rat brain membranes. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role.
More Information Supplier PageDizocilpine Maleate
Dizocilpine Maleate 10 mg | 99.96%
TargetMol
Dizocilpine Maleate (MK 801) is a potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) with Kd of 37.2 nM in rat brain membranes. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role.
More Information Supplier PageDizocilpine Maleate
Cetilistat 100 mg | 99.88%
TargetMol
Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
More Information Supplier PageCetilistat
